Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
Clinical trial NCT04678505 · TERMINATED
Trial details
- NCT number
- NCT04678505
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-10
- Primary completion
- 2021-04-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.